AptaBio Therapeutics Inc.

₩4,900As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:293780Healthcare
Country South Korea
PE (Fwd) •••
TSR 7Y CAGR (11.18%)
Div yield —
ROE (33.15%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.90
PE TTM —
TSR TTM (30.10%)
Mkt cap ₩137.7B
ROIC (22.73%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩6,038
23.22%
(71.19%)
Sell 11|3|2|12|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
69.43
67.53
72.92
79.34
17.55%
7.17%
12.89%
15.54%
Revenue₩B
6.143
6.028
6.323
6.568
2.31%
(0.54%)
1.23%
4.23%
Peers (US$101.5M)
Cap (US$)
PE
106.9M
26.43x
106.3M
3.616x
105.2M
7.897x
Capital
TTM
5Y
10Y
Leveragex
17.38
0.028
0.027
EBIT/Intx
0.934
0.151
0.116
Own earn%
(384.59)
144.86
142.70
Sh yield%
29.60
14.72
15.52
Owners
Insiders/Inst%
4.87
70.42
Short interest%
3.05
SBC / revenue%
0.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
33